scPharmaceuticals
SCPH
SCPH was delisted on the 6th of October, 2025.
95 hedge funds and large institutions have $170M invested in scPharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 21 reducing their positions, and 6 closing their positions.
368% more call options, than puts
Call options by funds: $721K | Put options by funds: $154K
300% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 6
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
62% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 21
40% more capital invested
Capital invested by funds: $121M → $170M (+$48.8M)
23% more funds holding
Funds holding: 77 → 95 (+18)
2.69% less ownership
Funds ownership: 77.16% → 74.46% (-2.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
+$9.91M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$6.05M |
| 3 |
KCM
Kingdon Capital Management
New York
|
+$3.87M |
| 4 |
AIC
AWM Investment Company
New York
|
+$3.7M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.54M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$1.01M |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$952K |
| 4 |
Renaissance Technologies
New York
|
-$785K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$493K |
SCPH Hedge Fund Activity: Q3 2024 in Review
95 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in scPharmaceuticals (SCPH) for Q3 2024, worth a combined $170M — up 40% from $121M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new SCPH positions and 6 closed out — a net gain of 18 holders — while 34 added to existing stakes and 21 trimmed.
The largest buyer was Suvretta Capital Management, opening a new position worth an estimated $9.91M. The largest seller was Bank of Montreal, exiting entirely with an estimated $1.54M sold.
- 95 institutional investors held scPharmaceuticals (SCPH) as of Q3 2024, up from 77 in Q2 2024.
- Funds reported $170M of scPharmaceuticals stock for Q3 2024, up 40% quarter-over-quarter.
- 24 funds opened new scPharmaceuticals positions in Q3 2024 and 6 closed out, a net change of +18 holders.
- The largest scPharmaceuticals buyer in Q3 2024 was Suvretta Capital Management, an estimated $9.91M added.
- The largest scPharmaceuticals seller in Q3 2024 was Bank of Montreal, an estimated $1.54M sold.
Based on aggregated 13F filings for Q3 2024.